In vitro antiatherogenicity of extracts from Halimeda incrassata seaweed: antioxidant activity and smooth muscle cell migration studies by Costa-Mugica, A. et al.
4 Ars Pharm. 2013; 54(2): 04-11.
Editorial
» Investigación y conocimiento en Atención Farmacéutica: un binomio inseparable. 
Sabater-Hernández D, Faus MJ, Martínez-Martínez F.
Originales
» In vitro antiatherogenicity of extracts from Halimeda incrassata seaweed: antioxidant 
activity and smooth muscle cell migration studies.
Costa-Mugica A, Batista-González AE, Mondejar D, Soto Y, Brito V, Vázquez AM, 
Brömme D, Zaldívar-Muñoz C, Mancini-Filho J, Vidal-Novoa A.
» Dispensación de anticonceptivos hormonales en una farmacia comunitaria de 
Valladolid.
García Sevillano L, Lobato Moreno S.
» Importancia de los sistemas de información en programas de salud pública: bases 
de datos de pacientes diabéticos.
Uema SAN, Olivera ME.
» Cambios en el sistema de distribución de medicamentos en un hogar de ancianos: 
análisis sobre el consumo de medicamentos y errores de medicación.
Giovagnoli M, Uema SAN, Vega EM
» Análisis de sistemas bucoadhesivos.
Castán Urbano H, Morales Hernández ME, Clares Naveros B, Calpena 








Facultad de Biología. Departamento de 
Bioquímica. Universidad de La Habana
Calle 25 No. 455 entre J e I, Vedado, CP 10 





In vitro antiatherogenicity of extracts from Halimeda incrassata seaweed: 
antioxidant activity and smooth muscle cell migration studies.
Costa-Mugica A1, Batista-González AE1, Mondejar D1, Soto Y2, Brito V2, Vázquez AM2, Brömme D3, Zaldívar-
Muñoz C1, Mancini-Filho J4, Vidal-Novoa A1
1. Department of Biochemistry, Faculty of Biology, University of Havana, Cuba; 
2. Center for Molecular Immunology, Havana City, Cuba; 
3. Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Canada; 
4.Department of Food and Experimental Nutrition, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Brazil.
Competing interest / Conflicto de interes: 
Authors declared that there was no conflict of 
interest associated with this research work.
Fundings / Financiación: 
The research was funded by IFS grant 
F/4897-1. Partial funding was also provided 
by CIHR grant MOP24447, the Canadian 
Research Chair award (D.B.) and a personal 
grant from GSEP, offered by the Canadian 







Objetivos: El objetivo de este trabajo fue evaluar el potencial ateroprotector in vitro del alga Halimeda 
incrassata en la migración de células de músculo liso de ratón y la oxidación de lipoproteínas en 
relación con su actividad antioxidante.  
Material y métodos: La actividad antioxidante fue determinada mediante los métodos de inhibición 
de radicales DPPH y la Capacidad antioxidante total (ORAC). La actividad inhibitoria de la oxidación 
de  LDL mediada por iones Cu2+ se determinó por la cuantificación de  TBARS y dienos conjugados. 
El efecto del extracto acuoso sobre la migración de las células de músculo liso se evaluó en la línea de 
células de músculo liso aórtica de ratón MOVAS-1. 
Resultados: Se demostró el efecto inhibidor del extracto sobre la oxidación de LDL mediada por 
Cu2+. El extracto del alga causa inhibición dosis-dependiente de la formación  de TBARS  (IC50 = 0,8 
mg/mL) y dienos conjugados. Las algas tuvieron una alta actividad antioxidante en los ensayos 
realizados y podría estar relacionada con el contenido de compuestos fenólicos.
Conclusiones: Los resultados de este trabajo representan un paso más en la caracterización de 
la acción ateroprotectora de Halimeda incrassata y evidencian sus posibles aplicaciones como 
nutracéutico y/o fitofármaco.
PALABRAS CLAVES: antiaterogenicidad, H. incrassata, actividad antioxidante, células de 
musculatura lisa. 
ABSTRACT 
Aim: The aim of this work was to evaluate the in vitro atheroprotective potential of the seaweed 
Halimeda incrassata in smooth muscle cell migration and lipoprotein oxidation in relation to its 
antioxidant activity.
Material and methods: Antioxidant activity was determinate by DPPH• radical scavenging assay 
and ORAC method. The inhibitory effect of the aqueous extract on LDL oxidation mediated by Cu2+ 
ions was determinate by TBARS and conjugated diene quantification. The effect of the seaweed 
aqueous extract on smooth muscle cell migration was evaluated in MOVAS-1 mouse aortic smooth 
muscle cell.
Results: The inhibitory effect of the aqueous extract on lipoprotein oxidation mediated by Cu2+ was 
demonstrated. Seaweed extract caused dose-dependent inhibition of TBARS (IC50 = 0.8 mg/mL) and 
conjugated dienes formation. The seaweed had a high antioxidant activity in the assays performed. 
The activity could be related to the phenolic content of Halimeda incrassata.
Conclusions: In summary, the results of this study represent a further step in the characterization 
of the atheroprotective action of Halimeda incrassata and indicate the seaweed could be used for a 
nutraceutical and/or phytoterapeutic application. 
KEYWORDS: antiatherogenicity, Halimeda incrassata, antioxidant activity, smooth muscle cell. 
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INTRODUCTION
Atherosclerosis is characterized by lipoprotein retention 
and oxidative modification in the artery wall with 
subsequent oxidized LDL uptake and foam cell formation. 
As lesion progresses smooth muscle cells migrate from 
the tunica media to the arterial intima marking lesion 
advancement1. Oxidative stress is considered a causal 
factor in all stages of atherosclerosis development, from 
oxidative modification of lipoproteins to platelet activation 
and atherothrombosis2. Atherosclerosis is also considered a 
common factor of other diseases related to oxidative stress 
such as ischemic heart disease and in this field antioxidants 
have been attractive to decrease oxidative stress associated 
with plaque formation2. 
Seaweeds are marine organisms that have been consumed 
as an integral part of the traditional diet in Asian countries 
and they are becoming increasingly popular in the western 
world in association to their health boosting properties3,4. 
Seaweeds have relatively high amounts of bioactive 
phytochemicals such as polyphenols that are consistent 
with antioxidative properties3. 
Interestingly, the main effect of algae consumption 
has been associated with cardiovascular and intestinal 
health with the epidemiological data available indicating 
a correlation between seaweed consumption and low 
atherosclerosis-related morbidity and mortality4. The 
mechanisms for cardiovascular protection are beginning 
to be elucidated and have been so far mainly related to 
antioxidative, antihypertensive, anti-inflammatory and 
hypocholesterolemic effects4.   
In a previous study we showed that Halimeda incrassata 
was one of the most active specimens presenting 
antioxidant activity in an initial screening study using a 
lipoperoxidation model5. The seaweed has also shown 
antioxidant activity in the mouse hypothalamic cell6 and 
exerted neuroprotection5 and hepatoprotection7 in vivo. 
In the present study we investigated the antiatherogenic 
potential of Halimeda incrassata in two key events of 
atherogenesis: lipoprotein oxidation and smooth muscle 
cell migration in relation to its antioxidant activity. 
MATERIALS AND METHODS
Seaweed collection and hydrophilic extracts preparation
The seaweed Halimeda incrassata (Ellis) Lamouroux was 
collected in December 2010 in the Bajo de Santa Ana, La 
Habana (Cuba). Voucher specimens were authenticated by 
Dr. A.M. Suárez from Seaweeds Laboratory, at the Marine 
Research Center. Freshly collected specimens were washed 
with distilled water and dried at room temperature for 3-5 
days. Dry seaweed powder was extracted with distilled 
water (1:5 w/v) and centrifuged at 800 g and at 4ºC for 20 
minutes. Supernatant was recovered, lyophilized and kept 
at -20ºC until use. Weight yield of the final extract in terms 
of dry seaweeds was 5.7%.
A polyphenol-rich fraction containing free phenolic 
acids (FPA) was obtained according to Krygier et al.8 Dry 
seaweed was extracted with tetrahydrofuran for 3 min, 
and evaporated to dryness under vacuum at 30ºC and the 
pellet was resuspended in ethanol. Total phenolic content 
was determined as in Vidal et al.9 and expressed as mg of 
gallic acid (GAE)/g of seaweed.
DPPH• radical scavenging assay
The DPPH• radical scavenging method was realized 
according Goupy et al.10 and the results are expressed as 
percent decrease from the initial DPPH• radical absorption 
by the test samples and calculation of the value of 50% 
inhibitory concentration (IC50).
Oxygen Radical Absorbance Capacity (ORAC)
The ORAC assay was determined according to Gillespie 
et al.11 using AAPH as a peroxyl radical generator. ORAC 
values were given as trolox equivalents. 
Inhibitory activity on LDL oxidation mediated by Cu2+ 
ions
LDL was isolated from human plasma by sequential 
ultracentrifugation as in Frostegard et al.12. LDL was 
oxidized with 10 µM CuSO4 and degree of oxidation was 
determined by TBARS and expressed as nmoles MDA 
equivalents/mg protein.
Conjugated diene formation was also monitored as in 
Esterbauer et al.13. Kinetic parameters lag phase, Vmax and 
Dienemax were determined according to Pinchuk et al.14.
Inhibition of smooth muscle cell migration
Smooth muscle cell (SMC) migration experiments were 
done with mouse aortic smooth muscle cells MOVAS-1, 
generously provided by Dr. Mansoor Hussain from the 
Heart and Stroke Richard Lewar Center of Excellence in 
Cardiovascular Research (Canada). Cells were cultured 
in DMEM containing FBS, 2 mM L-glutamine and 
streptomycin/penicillin in 5% CO2 atmosphere. All 
experiments were performed with MOVAS-1 SMC between 
passages 5 to 15. 
In the wound healing assay smooth muscle cells were grown 
to 90% confluence in DMEM + 10% FBS. After damaging 
the monolayers with a sterile tip, cells were treated with 5 
ng/mL Platelet derived growth factor and seaweed extract 
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Figure 1. Antioxidant activity of the aqueous extract of 
Hi in the DPPH• radical scavenging assay. The assay 
was performed according to Goupy et al.10.Data are 
given as mean ± s.d (n=3).
Figure 2. Total antioxidant capacity by ORAC assay as 
previously described in methods. Data is presented as 
average RFU where s.d < 10 % of mean RFU. 
and allowed to migrate for 16 hours. Cells were stained 
with crystal violet and after taking photographs distance 
migrated were calculated as described by Ho et al.15. 
Transmigration experiments were done as in Goncharova 
et al.16 with some modifications. Cells were incubated for 16 
hours and after swabbing the upper part, membranes were 
fixed with methanol and then stained with crystal violet. 
Transmigrated cells were counted under a microscope at 
100x; 10 fields were counted/insert.
Statistical analysis
Values are given as mean + standard deviation (s.d.). For 
statistical significance an unpaired student´s t test was 
performed. Data was processed using Microcal Origin 5.0 
and GraphPad Prism software (version 3.01 for Windows). 
p < 0.05 was considered statistically significant. 
RESULTS
Phenolic content
H.incrassata had a high total phenolic content with 2.8 µg 
GAE/mg for the lyophilized aqueous extract and 14.1 µg 
GAE/g of dry seaweed for the FPA fraction.
DPPH• scavenging capacity of the extract
As shown in Figure 1, H. incrassata extract presents a 
concentration dependent free radical scavenging activity, 
with an IC50 of 0.27 + 0.011 mg/mL.
ORAC
Antioxidant activity by the ORAC assay is shown in Figure 
2. The total antioxidant capacity was higher with increasing 
concentrations of seaweed with an ORAC value of 3960 
trolox equivalents/g of dry seaweed. 










 Hi 2 ug 
 Hi 1 ug  
 Hi 0.5 ug
 FPA 8 ug 
 FPA 0.8 ug
Figure 3. Effect of Hi on LDL oxidation induced by Cu2+ ions. A. Inhibition of TBARS formation during LDL oxidation. B. 
Conjugated dienes formation during LDL oxidation. Results are presented as mean ±  s.d. (n=3).
Inhibition of LDL oxidation
The dose response for inhibition of lipoperoxidation during 
LDL oxidation mediated by Cu2 is shown in Figure 3.A with 
IC50 of 0.8 mg/mL while as shown in Figure 3.B conjugated 
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Table 1. Effect of Hi on kinetics of LDL oxidation mediated by Cu2+ ions. Results are presented as mean ± s.d. (n=3). 
* Significant differences for p < 0.05 vs LDL + Cu2+
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diene formation. The kinetic parameters lag phase, Vmax 
and Diene max were presented in Table 1.    
Antimigratory activity 
The effect of H. incrassata on PDGF-BB-induced MOVAS-1 
SMC migration is shown in Table 2. 
DISCUSSION 
Oxidative stress has been critically involved in the 
progression of atherosclerosis with natural antioxidant 
extracts being presently studied for potential disease 
modulation2. In this work we further evaluated the in 
vitro antiatherogenic properties of H. incrassata and its 
antioxidant activity in cell free systems.  
A high phenolic content was found for hydrophilic fractions 
from H. incrassata, which is similar to the one reported 
by our group for other seaweeds from the Halimeda spp9. 
Likewise Yoshie et al.17 showed that there was a high 
polyphenols content in the seaweeds H. opuntia and H. 
macroloba and identified a variety of phenolic compounds 
that could be relevant to the antioxidant properties.
The high DPPH• scavenging capacity for H. incrassata 
lyophilized is in the range of the one reported for other 
seaweeds in the literature in different regions. Heo et al.18 
obtained a 70 % DPPH• scavenging in hydrophilic extracts 
from E. cava; an activity that correlated to phenolic content. 
Additionally our group informed an IC50 of 1,18 mg/mL 
for the seaweed Bryothamnion triquetrum19 whereas H. 
incrassata - with a significantly higher phenolic content - is 
about 4 times more effective in DPPH• scavenging. 
Likewise Serevinathne et al.20 found an association between 
antioxidant capacity in DPPH• scavenging and solvent 
polarity; which also was related to a higher phenolic content 
in these fractions. The authors found a similar antioxidant 
activity pattern for other assays such as inhibition of 
lipoperoxidation.  
Together with DPPH• radical scavenging and inhibitory 
action on lipoprotein oxidation H. incrassata also exhibited 
a high total antioxidant capacity in the range found for 
other natural extracts21. In hydrophilic extracts the activity 
was similar for the aqueous extract and the polyphenol 
rich FPA fraction indicating that phenolic compounds 
are important in the effect observed. Likewise Price et al.22 






LDL + Cu2+ 20.58 + 2.96 0.57 + 0.01 16.7 + 0.55
LDL + Cu2+
 
+ Hi 0.01 mg/mL 28.9 + 6.64 0.49 + 0.04 16.1 + 0.28
LDL + Cu2+
 
+ Hi 0.05 mg/mL 42 + 6.50* 0.47 + 0.07* 16.65 + 0.35
Kinetic parameters:
Lag phase: Time of resistance 
to oxidation of LDL, where 
conjugated dienes have not 
formed yet. 
Vmax: Maximum rate of 
conjugated diene formation.
Dienes max: Maximum 
formation of conjugated dienes.  
Table 2. Effect of Halimeda incrassata seaweed on smooth muscle cell migration in MOVAS-1 mouse aortic smooth muscle cell 
line. The experiment was performed as previously described by Zargham et al.17
Results are expressed as mean + s.d of each experiment performed in triplicate. Significant differences for p < 0.05 compared to 





+ PDGF + H. incrassata 1 mg/mL 30.2 + 2.55 *
+ PDGF + H. incrassata 0.5 mg/mL 40.3 + 4.56 *
+ PDGF + H. incrassata 0.1 mg/mL 46.9 + 1.12 *
Transwell assay
Transmigrated cells
 (% of control) 
control 100   + 7.78
PDGF 460.3 + 37.06
PDGF + H. incrassata 1 mg/mL 227.5 + 21.51 *
PDGF + H. incrassata 0.1 mg/mL 262.5 + 17.68 *
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seaweed extracts; where the highest activity correlated to 
the presence of hydrophilic compounds. 
Previous work has shown that the main phenolic compounds 
in H. incrassata are phenolic acids with a majoritary 
composition of salicylic and lower quantities of ferulic 
acid that might also contribute to the antioxidant action23. 
Salicylic acid is relevant in plant defence mechanisms and 
has antinflammatory and antioxidant properties related 
to lypoxygenase inhibition and to decrease of endothelial 
cells adhesion molecules expression24. 
LDL oxidation is a key therapeutic target as it is a main 
emerging risk factor for cardiovascular diseases. Indeed 
from fatty streak formation to thrombosis in advanced 
plaques oxidized LDL has a relevant role in atherosclerosis 
related events such as migration and proliferation of 
smooth muscle cells and endothelial dysfunction2. To help 
dilucidate the mechanism behind antioxidant action in 
inhibition of LDL oxidation conjugated diene formation 
was monitored in presence of seaweed aqueous extract. 
During LDL oxidation by Cu2+ the metal binds to LDL 
and catalyses the constant formation of free radicals at 
the expense of the reduction of antioxidants bound to the 
particle14. The variation in oxidation kinetics with increase 
in the lag phase and decrease in Vmax on addition of 
aqueous extract could be indicative of a chelating effect 
of Cu2+ or result from the blockage of the sites of binding 
of cupper to the lipoprotein14. Polyphenolic compounds 
found in the extract could be relevant in this effect since 
it is known that polyphenols that act through free radical 
scavenging can also efficiently bind transition metals. The 
in vitro antioxidant activity assays indicate that inhibition 
of LDL oxidation could be attained potentially by both Cu2+ 
chelating and free radical scavenging, where the phenolic 
content and antioxidant activity could contribute to this 
effect. 
LDL oxidation in vivo is a complex process not fully 
understood and Cu2+ mediated oxidation is a model 
frequently used to study lipoperoxidation reactions that 
could take place in the vascular wall14. The protective 
effect in TBARS formation found for H. incrassata extract 
could be associated to the presence of significant amounts 
of hydrophilic antioxidants involved in scavenging of free 
radicals formed in the aqueous phase. 
Several groups have evaluated the antiatherogenicity of 
natural extracts against LDL oxidation finding an activity 
that correlates to phenolic content. The antilipoperoxidative 
activity found in our study is quite promising as compared 
to other previously reported natural extracts. For instance 
a 37 % inhibition of TBARS formation was found in AAPH 
and 74 % in Cu2+ peroxidation by Hseu et al.25. In that study 
T. sinensis extracts had 6.5 μg GAE; a phenolic content 
higher than the one needed in our study to reach 50 % 
inhibition of TBARS formation in both oxidation systems 
used, adding therefore further evidence to the antioxidant 
potential of H. incrassata.    
Antiatherogenic properties of natural extracts in 
smooth muscle cell biology is another field of relevance 
in cardioprotection as these are key cell types in the 
pathogenesis of vascular disease26. Their migration from 
tunica media to subendothelial space marks the transit 
from the fatty streak to more advanced lesions; since they 
produce most of extracellular matrix generated during the 
plaque fibroproliferative response. PDGF secreted locally is 
the most potent stimulus for smooth muscle cell migration 
and signalling through its receptor is associated with ROS 
production resulting from NADPH oxidase activation27.
Thereafter antioxidants have been of interest for targeting 
smooth muscle cell migration by several authors. 
Polyphenol rich natural extracts such as those from tea 
and cocoa28 have shown inhibition of smooth muscle cell 
migration whereas several pure phenolic compounds like 
the phenolic acid derivative avenanthramide also had 
antioxidant activity in smooth muscle cells increasing NO 
production by upregulation of eNOS mRNA29. 
The 43% inhibition of migration in the transwell assay and 
the decrease migrated area in the wound scratch model 
found in our study, are consistent with the results for other 
natural extracts in the literature. Zargham et al.30  had a 62% 
antimigratory activity in the transwell assay with a tannin 
extract. Likewise Ho et al.15 evaluated the effect on smooth 
muscle cell migration of the water extracts from Nelumbo 
nucifera -an aquatic plant used in traditional medicine-, to 
elucidate the molecular mechanisms of its antiatherogenic 
action. They found a decrease by 60 % at 0.2 mg/mL in 
transmigrated cells and decreased inhibition in a wound 
closure assay, effects the authors discussed that were 
probably related to the high content of phenolic acids and 
flavonoids of the extract. 
Though the mechanisms of action involved in the 
antimigratory activity are unknown it could be speculated 
that it might be related to a direct antioxidant action or 
to antioxidant enzyme induction capable of modulating 
migration of these cells. 
In the other hand the considerable inhibitory activity of 
the lyophilized aqueous extract of the seaweed on PDGF-
BB induced smooth muscle cell migration adds further 
evidence to the potential of H. incrassata for targeting 
Ars Pharm. 2013; 54(2): 04-11.
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atherosclerosis progression and to our knowledge it is the 
first report of inhibition of smooth muscle cell migration by 
seaweed extracts. 
CONCLUSION
Our previous work has indicated an antiatherogenic effect 
of the seaweed in atherosclerosis progression in apo E-/- 
mice31. The present study adds evidence to a potential 
atheroprotective application of H. incrassata considering its 
antioxidant action and its high activity for targeting LDL 
oxidation and smooth muscle cell migration. Thereafter 
further studies are needed for elucidating the molecular 
mechanisms involved in the in vitro and in vivo effects 
observed to propose H. incrassata extracts for cardiovascular 
protection. 
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